The proinflammatory interleukin-21 elicits anti-tumor response and mediates autoimmunity

International Journal of Immunopathology and Pharmacology

Volumn 19, Issue 2, 2006, Pages 247-251

  Castellani, M L ^a   Salini, V ^a   Frydas, S ^b   Donelan, J ^c   Tagen, M ^c   Madhappan, B ^c   Petrarca, C ^a   Falasca, K ^a   Neri, G ^a   Tete, S ^a   Vecchiet, J ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR; CYTOKINE; INTERLEUKIN 11; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 4; INTERLEUKIN 7; INTERLEUKIN 9; JANUS KINASE 3;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; DENDRITIC CELL; EDITORIAL; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTE; LYMPHOID TISSUE; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 33746819779     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200601900201     Document Type: Editorial

References (49)

1. Petrarca C., S. Frydas, J. Donelan, W. Boucher, N. Papadopoulou, J. Cao, M.L. Castellani, P. Conti, E. Toniato, I. Robuffo, J. Vecchiet, T. Iezzi, B. Madhappan and D. Kempuraj. 2005. Interleukin 27 (IL-27): a novel pleiotropic cytokine involved in T cell differentiation and T cell response modulation. Int. J. Immunopathol. Pharmacol. 18:191.
2. Musso T., P. Cappello, S. Stornello, D. Ravarino, C. Caorsi, K. Otero, F. Novelli, R. Badolato and M. Giovarelli. 2005. IL-10 enhances CCL2 release and chemotaxis induced by CCL16 in human monocytes. Int. J. Immunopathol. Pharmacol. 18:339.
3. Di Giannantonio M., S. Frydas, D. Kempuraj, E. Karagouni, M. Hatzistilianou, C.M.V. Conti, W. Boucher, N. Papadopoulou, J. Donelan, J. Cao, B. Madhappan, P. Boscolo, C. Petrarca, L. Castellani, R. Quartesan, R. Doyle and F.M. Ferro. 2005. Cytokines in stress. Int. J. Immunopathol. Pharmacol. 18:1.
4. Alexandrakis M.G., F.H. Passam, C.A. Pappa, J. Damilakis, G. Tsirakis, E. Kandidaki, E.N. Stathopoulos and D.S. Kyriakou. 2005. Serum evaluation of angiogenic cytokines basic fibroblast growth factor, hepatocyte growth factor and TNF-α in patients with myelodysplastic syndromes: correlation with bone marrow microvascular density. Int. J. Immunopathol. Pharmacol. 18:287.
5. Pelletier M., A. Bouchard and D. Girard. 2004. In vivo and in vitro roles of IL-21 in inflammation. J. Immunol. 173:7521.
6. Gorbunov N.V., S.J. McFaul, A. Januszkiewicz and J.L. Atkins. 2005. Proinflammatory alterations and status of blood plasma iron in a model of blast-induced lung trauma. Int. J. Immunopathol. Pharmacol. 18:547.
7. Totaro R., A. Passacantando, T. Russo, I. Parzanese, M. Rascente, C. Marini, G. Tonietti and A. Carolei. 2005. Effects of interferon beta, cyclophosphamide, and azathioprine on cytokine profile in patients with multiple sclerosis. Int. J. Immunopathol. Pharmacol. 18:377.
8. Matalon R., S. Surendran, J.D. McDonald, A.O. Okorodudu, S.K. Tyring, K. Michals-Matalon and P. Harris. 2005. Abnormal expression of genes associated with development and inflammation in the heart of mouse maternal phenylketonuria offspring. Int. J. Immunopathol. Pharmacol. 18:557.
9. Strengell M., T. Sareneva, D. Foster, I. Julkunen and S. Matikainen. 2002. IL-21 up-regulates the expression of genes associated with innate immunity and Th1 response. J. Immunol. 169:3600.
10. Yamaki K., H. Uchida, X. Li, R. Yanagisawa, H. Takano, H. Hayashi, Y. Mori and S. Yoshino. 2005. Effect of varying types of anti-arthritic drugs on Th1 and Th2 immune responses in mice. Int. J. Immunopathol. Pharmacol. 18:133.
11. Falkensammer B., W. Fasser, K. Scherer, A. Zemann, W. Parson, H. Ulmer, M.P. Dierich and H. Stoiber. 2005. Drug monitoring and viral response to lopinavir/ritonavir or saquinavir/ritonavir containing regimens in individuals infected with the Human Immunodeficiency Virus Type 1. Int. J. Immunopathol. Pharmacol. 18:145.
12. Leonard W.J. and R. Spolski. 2005. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat. Rev. Immunol. 5:688.
13. Martini F., C. Agrati, G. D'Offizi and F. Poccia. 2005. HLA-E up-regulation induced by HIV infection may directly contribute to CD94-mediated impairment of NK cells. Int. J. Immunopathol. Pharmacol. 18:269.
14. Cognasse F., P. Chavarin, S. Acquari, O. Sapido, L. Beniguel, C. Genin, Y. Richard and O. Garraud. 2005. Differential downstream effects of ligation mediated by membrane or soluble CD40L and agnostic Ab: a study on purified human B cells. Int. J. Immunopathol. Pharmacol. 18:65.
15. Esposito I., F. Perna, A. Ponticiello, M. Perrella, M. Gilli and A. Sanduzzi. 2005. Natural Killer cells in BAL and peripheral blood of patients with idiopathic pulmonary fibrosis (IPF). Int. J. Immunopathol. Pharmacol. 18:541.
16. Parrish-Novak J., S.R. Dillon, A. Nelson, A. Hammond, C. Sprecher, J.A. Gross, et al. 2000. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408:57.
17. Lanzilli G., R. Falchetti, M. Tricarico, D. Ungheri and M.P. Fuggetta. 2005. In vitro effects of an immunostimulating bacterial lysate on human lymphocyte function. Int. J. Immunopathol. Pharmacol. 18:245.
18. E. Karagouni, F. Athanassopoulou, P. Tsagozis, E. Ralli, T. Moustakareas, K. Lytra and E. Dotsika. 2005. The impact of a successful anti-myxosporean treatment on the phagocyte functions of juvenile and adult Sparus Aurata L. Int. J. Immunopathol. Pharmacol. 18:121.
19. Zeng R., R. Spolski, S.E. Finkelstein, S. Oh, P.E. Kovanen, C.S. Hinrichs, et al. 2005. Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. J. Exp. Med. 201:139.
20. P. Somma, L. Lo Muzio, G. Mansueto, M. Delfino, G. Fabbrocini, M. Mascolo, C. Mignogna, M. Di Benedetto, F. Carinci, R. Serpico, G. De Rosa and S. Staibano. 2005. Squamous cell carcinoma of the lower lip: Fas/FasL expression, lymphocyte subtypes and outcome. Int. J. Immunopathol. Pharmacol. 18:59.
21. Marinova S., P. Nenkov, R. Markova, S. Nikolaeva, R. Kostadinova, I. Mitov and M. Vretenarska. 2005. Cellular and humoral systemic and mucosal immune responses stimulated by an oral polybacterial immunomodulator in patients with chronic urinary tract infections. Int. J. Immunopathol. Pharmacol. 18:457.
22. Collins M., M.J. Whitters and D.A. Young. 2003. IL-21 and IL-21 receptor: a new cytokine pathway modulates innate and adaptive immunity. Immunol. Res. 28:131.
23. Galdiero M., M.G. Pisciotta, F. Gorga, G. Petrillo, A. Marinelli and E. Galdiero. 2005. Modulation of costimulating molecules CD80/CD86 on B cells and macrophages by stress proteins GroEL, GroES and Dna K. Int. J. Immunopathol. Pharmacol. 18:637.
24. Avgerinos D.V. and T.C. Theoharides. 2005. Mesenteric traction syndrome or gut in distress. Int. J. Immunopathol. Pharmacol. 18:195.
25. Habib T., S. Senadheera, K. Weinberg and K. Kaushansky. 2002. The common gamma chain (gamma c) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3. Biochemistry 41:8725.
26. Brunetti L., C. Di Nisio, G. Orlando, C. Ferrante and M. Vacca. 2005. The regulation of feeding: a cross talk between peripheral and central signalling. Int. J. Immunopathol. Pharmacol. 18:201.
27. Ballerini P., R. Ciccarelli, F. Caciagli, M.P. Rathbone, E.S. Werstiuk, U. Traversa, S. Buccella, P. Giuliani, S. Jiang, E. Nargi, D. Visini, C. Santavenere and P. Di Iorio. 2005. P2X7 receptor activation in rat brain cultured astrocytes increases the biosynthetic release of cysteinyl leukotrienes. Int. J. Immunopathol. Pharmacol. 18:417.
28. Habib T., A. Nelson and K. Kaushansky. 2003. IL-21: a novel IL-2-family lymphokine that modulates B, T, and natural killer cell responses. J. Allergy Clin. Immunol. 112:1033.
29. Bernardini R., G. Mistrello, E. Novembre, D. Roncarolo, S. Zanotta, E. Lombardi, A. Cianferoni, N. Pucci, M. De Martino and A. Vierucci. 2005. Cross-reactivity between IgE-binding proteins from Anisakis simplex and Dermatophagoides pteronyssinus. Int. J. Immunopathol. Pharmacol. 18:671.
30. Ballerini P., P. Di Iorio, R. Ciccarelli, F. Caciagli, A. Poli, A. Beraudi, S. Buccella, I. D'Alimonte, M. D'Auro, E. Nargi, P. Patricelli, D. Visini and U. Traversa. 2005. P2Y1 and cysteinyl-leukotriene receptors mediate purine and cysteinyl-leukotriene co-release in primary cultures of rat microglia. Int. J. Immunopathol. Pharmacol. 18:255.
31. Bonsi L., L. Pierdomenico, M. Biscardi, C. Marchionni, S. Gavazzi, V. Fossati, B. Ghinassi, F. Alviano, D. Rondelli, M. Franchina, G.P. Bagnara and A. Grossi. 2005. Constitutive and stimulated production of VEGF by human megakaryoblastic cell lines: effect on proliferation and signaling pathway. Int. J. Immunopathol. Pharmacol. 18:445.
32. Benczik M. and S.L. Gaffen. 2004. The interleukin (IL)-2 family cytokines: survival and proliferation signalling pathways in T lymphocytes. Immunol. Invest. 33:109.
33. Appert-Collin A., F.H.T. Duong, P. Passilly Degrace, J.M. Warter, P. Poindron and J.P. Gies. 2005. MAPK activation via 5-hydroxytryptamine 1A receptor is involved in the neuroprotective effects of xaliproden. Int. J. Immunopathol. Pharmacol. 18:2.
34. L. Centurione, C. Di Giulio, E. Santavenere, M. Cacchio, N. Sabatini, C. Rapino, G. Bianchi, M. Rapino, D. Bosco, A. Antonucci and A. Cataldi. 2005. Protein kinase C zeta regulation of hypertrophic and apoptotic events occurring during rat neonatal heart development and growth. Int. J. Immunopathol. Pharmacol. 18:49.
35. Herrin B.R. and L.B. Justement. 2006. Expression of the adaptor protein hematopoietic Src homology 2 is up-regulated in response to stimuli that promote survival and differentiation of B cells. J. Immunol. 176:4163.
36. Caproni M., D. Torchia, E. Antiga, D. Degl'Innocenti, E. Barletta, G. Baroni, M. Santucci and P. Fabbri. 2005. The role of apoptosis in the pathogenesis of dermatitis herpetiformis. Int. J. Immunopathol. Pharmacol. 18:691.
37. Gonzalez M.I., N. Rubinstein, J.M. Ilarregui, M.A. Toscano, N.A. Sanjuan and G.A. Rabinovich. 2005. Regulated expression of Galectin-1 after in vitro productive infection with herpes simplex virus type I: implications for T cell apoptosis. Int. J. Immunopathol. Pharmacol. 18:615.
38. Ottonello L., M. Bertolotto, F. Montecucco, P. Dapino and F. Dallegri. 2005. Dexamethasone-induced apoptosis of human monocytes exposed to immune complexes. Intervention of CD95- and XIAP-dependent pathways. Int. J. Immunopathol. Pharmacol. 18:403.
39. Vinuesa C.G., M.C. Cook, C. Angelucci, V. Athanasopoulos, L. Rui, K.M. Hill, D. Yu, H. Domaschenz, B. Whittle, T. Lambe, I.S. Roberts, R.R. Copley, J.I. Bell, R.J. Cornall and C.C. Goodnow. 2005. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435:452.
40. Gallegos A.M. and M.J. Bevan. 2004. Driven to autoimmunity: the nod mouse. Cell 117:149.
41. Perrella A., G. Borgia, F. Borrelli, S. Di Sirio, M. Gnarini, S. Grattacaso, M. Graf, M. Guida, C. Viola, M. Guarnaccia and O. Perrella. 2005. TNF-α serum level elevations in chronic hepatitis C patients with diabetes mellitus. Int. J. Immunopathol. Pharmacol. 18:189.
42. Guidi L., M. Costanzo, M. Ciarniello, I. De Vitis, C. Pioli, L. Gatta, L. Pace, A. Tricerri, C. Bartoloni, L. Coppola, P. Balistreri, G. Doria, G. Fedeli and G.B. Gasbarrini. 2005. Increased levels of NF-kB inhibitors (IκBγ and IκBγ) and in the intestinal mucosa of Crohn's disease patients during infliximab treatment. Int. J. Immunopathol. Pharmacol. 18:155.
43. Licastro F., M. Chiappelli, M. Ruscica, V. Carnelli and M.M. Corsi. 2005. Altered cytokine and acute phase response protein levels in the blood of children with Down's syndrome: relationship with dementia of Alzheimer's type. Int. J. Immunopathol. Pharmacol. 18:165.
44. Kovanen P.E. and W.J. Leonard. 2004. Cytokines and immunodeficiency diseases: critical roles of the gamma(c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways. Immunol. Rev. 202:67.
45. Ma H.L., M.J. Whitters, R.F. Konz, M. Senices, D.A. Young, M.J. Grusby, et al. 2003. IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perform but are independent of IFN-gamma. J. Immunol. 171:608.
46. Wang G., M. Tschoi, R. Spolski, Y. Lou, K. Ozaki, C. Feng, et al. 2003. In vivo antitumor activity of interleukin 21 mediated by natural killer cells. Cancer Res. 63:9016.
47. Di Carlo E., A. Comes, A.M. Orengo, O. Rosso, R. Meazza, P. Musini, et al. 2004. IL-21 induces tumor rejection by specific CTL and IFNgamma-dependent CXC chemokines in syngeneic mice. J. Immunol. 172:1540.
48. R. Sessa, G. Schiavoni, M. Di Pietro, A. Petrucca, P. Cipriani, C. Zagaglia, S. Fallucca and M. del Piano. 2005. Chlamydia pneumoniae in PBMC: reproducibility of the ompa nested touchdown PCR. Int. J. Immunopathol. Pharmacol. 18:113.
49. Frydas S., N. Papaioannou, M. Papazahariadou, M. Hatzistylianou, E. Karagouni, M. Trakatelli, G. Brellou, C. Petrarca, M.L. Castellani, P. Conti, G. Riccioni and A. Grilli. 2005. Inhibition of MCP-1 and MIP-2 chemokines in murine trichinellosis: effect of the anti-inflammatory compound 1-mimosine. Int. J. Immunopathol. Pharmacol. 18:85.